Crcm - Centre De Recherche En Cancérologie De Marseille

Crcm - Centre De Recherche En Cancérologie De Marseille company information, Employees & Contact Information

Un continuum dans la recherche sur le cancer, de la recherche fondamentale à la recherche translationnelle et clinique Le Centre de Recherche en Cancérologie de Marseille (CRCM) est affilié à l’Inserm (UMR1068), au CNRS (UMR7258), à l’Université Aix-Marseille (UM105) et au Centre de Lutte Contre le Cancer de la région PACA, l’Institut Paoli-Calmettes (IPC). Il comprend près de 450 personnes dans 19 équipes et 18 plateformes/plateaux technologiques coordonnés sous forme d’un Core Tech. C’est un centre avec plus de 25 nationalités représentées, collaborant avec les plus grands instituts nationaux et internationaux et membre de multiples réseaux d’excellence de recherche sur le cancer. Le CRCM est également fortement impliqué dans la formation par le biais de son implication dans les parcours de Masters et de Doctorat de l’Université Aix-Marseille et les Instituts universitaires en Cancer et Immunologie, Imagerie et Intelligence Artificielle.
Looking for a particular Crcm - Centre De Recherche En Cancérologie De Marseille employee's phone or email?

Crcm - Centre De Recherche En Cancérologie De Marseille Questions

News

Nelson Dusetti Announces the 1st CRCM Symposium on Translational Oncology - Oncodaily

Nelson Dusetti Announces the 1st CRCM Symposium on Translational Oncology Oncodaily

CRCM Symposium 2026 - Oncodaily

CRCM Symposium 2026 Oncodaily

Establishment of a mouse hepatocellular carcinoma tumoroid panel recapitulating inter- and intra- heterogeneity for disease modelling and combinatorial drug discovery - Cell Communication and Signaling

Establishment of a mouse hepatocellular carcinoma tumoroid panel recapitulating inter- and intra- heterogeneity for disease modelling and combinatorial drug discovery Cell Communication and Signaling

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active - Nature

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active Nature

Nelson Dusetti: CRCM is looking for a postdoctoral researcher - Oncodaily

Nelson Dusetti: CRCM is looking for a postdoctoral researcher Oncodaily

Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study - Nature

Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study Nature

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms - The Lancet

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms The Lancet

Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression - EMBO Press

Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression EMBO Press

Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia - Frontiers

Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia Frontiers

Improving AutoDock Vina Using Random Forest: The Growing Accuracy of Binding Affinity Prediction by the Effective Exploitation of Larger Data Sets - Wiley Online Library

Improving AutoDock Vina Using Random Forest: The Growing Accuracy of Binding Affinity Prediction by the Effective Exploitation of Larger Data Sets Wiley Online Library

Journal of Contemporary Brachytherapy - Termedia

Journal of Contemporary Brachytherapy Termedia

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer - Dove Medical Press

Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer Dove Medical Press

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation - Clinical Epigenetics

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation Clinical Epigenetics

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells - Nature

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells Nature

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication - Nature

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication Nature

Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA - Nature

Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA Nature

Top Crcm - Centre De Recherche En Cancérologie De Marseille Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant